<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02319083</url>
  </required_header>
  <id_info>
    <org_study_id>1</org_study_id>
    <nct_id>NCT02319083</nct_id>
  </id_info>
  <brief_title>Outcome After Coronary Artery Bypass Grafting</brief_title>
  <acronym>E-CABG</acronym>
  <official_title>E-CABG: European Multicenter Study on the Outcome After Coronary Artery Bypass Grafting</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oulu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Universita di Verona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ospedali Riuniti Trieste</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Catania</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Leicester</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>San Camillo Hospital, Rome</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>S. Anna Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Paracelsus Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Campania &quot;Luigi Vanvitelli&quot;</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Parma</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Bari</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centro Cardiologico Monzino</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Hamburg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Genova</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Oulu</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The E-CABG registry is a multicenter, European registry collecting data on the preoperative
      characteristics, treatment strategies and outcome of patients undergoing isolated coronary
      artery bypass grafting (CABG).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Improvements in the surgical treatment of coronary artery disease are possible only when
      implementation of current methods and development of new methods are based on the solid
      ground of large and reliable clinical data. Furthermore, clinical findings assume even more
      significance when detected in study populations from different institutions with
      heterogeneous referral pathways, baseline clinical characteristics and perioperative
      treatment strategies. The rationale of this European multicenter study is therefore to
      prospectively collect data on baseline characteristics, operative and anesthesiological
      methods and postoperative outcome of patients undergoing CABG in eleven cardiac surgery
      centers from five European countries. This multicenter prospective registrywill provide data
      to evaluate the prognostic impact of a number of patients' risk factors as well as the
      efficacy and safety of operative methods and drugs used during the pre-, peri- and
      postoperative period.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>The outcome measure will be assessed at time points up to 10 years after surgery</time_frame>
    <description>Any death occurring after surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stroke</measure>
    <time_frame>The outcome measure will be assessed at time points up to 10 years after surgery</time_frame>
    <description>Any ischemic brain injury occurring after surgery and lasting &gt; 24 hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prolonged use of inotropes</measure>
    <time_frame>Participants will be followed for the duration of hospital stay (expected: 10 days)</time_frame>
    <description>Use of inotropes &gt; 12 hours after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra-aortic balloon pump</measure>
    <time_frame>Participants will be followed for the duration of hospital stay (expected: 10 days)</time_frame>
    <description>Use of intra-aortic balloon pump for acute heart failure after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ECMO</measure>
    <time_frame>Participants will be followed for the duration of hospital stay (expected: 10 days)</time_frame>
    <description>Use of extracorporeal membrane oxygenation for acute heart failure after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Repeat revascularization</measure>
    <time_frame>The outcome measure will be assessed at time points up to 10 years after surgery</time_frame>
    <description>Any repeat myocardial revascularization procedure performed after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wound infection</measure>
    <time_frame>Participants will be followed up for 3 months after surgery</time_frame>
    <description>Any deep sternal or lower limb wound infection occurring after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood losses</measure>
    <time_frame>Participants will be followed 12 hours after surgery</time_frame>
    <description>Amont of blood losses from drainages 12 hours after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nadir hematocrit</measure>
    <time_frame>Participants will be followed during the operation day</time_frame>
    <description>Lowest hematocrit level during the operation day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of blood products</measure>
    <time_frame>Participants will be followed for the duration of hospital stay (expected: 10 days)</time_frame>
    <description>Use of any blood product (red blood cell, fresh frozen plasma, Octaplas, platelets) during the in-hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of prothrombotic drugs</measure>
    <time_frame>Participants will be followed for the duration of hospital stay (expected: 10 days)</time_frame>
    <description>Perioperative use of cryoprecipitate, PCC and/or rFVIIa for excessive bleeding
PCCs
Perioperative use of rFVIIa, PCC, cryoprecipitate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resternotomy for bleeding</measure>
    <time_frame>Participants will be followed for the duration of hospital stay (expected: 10 days)</time_frame>
    <description>Re-exploration for excessive bleeding</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Atrial fibrillation</measure>
    <time_frame>Participants will be followed for the duration of hospital stay (expected: 10 days)</time_frame>
    <description>New episode of atrial fibrillation requiring or not cardioversion during the in-hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renal replacement therapy</measure>
    <time_frame>Participants will be followed for the duration of hospital stay (expected: 10 days)</time_frame>
    <description>Any renal replacement therapy during the in-hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Highest level of serum creatinine</measure>
    <time_frame>Participants will be followed for the duration of hospital stay (expected: 10 days)</time_frame>
    <description>Highest level of serum creatinine during the in-hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarction</measure>
    <time_frame>The outcome measure will be assessed at time point up to 10 years after surgery</time_frame>
    <description>Myocardial infarction (diagnosed by ECG and troponin monitoring) any time after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay in the intensive care unit</measure>
    <time_frame>Participants will be followed for the duration of hospital stay (expected: 10 days)</time_frame>
    <description>Length of stay in the intensive care unit after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pericardial effusion</measure>
    <time_frame>Participants will be followed up to 3 months after surgery.</time_frame>
    <description>Pericardial effusion requiring medical or surgical treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative use of antibiotics</measure>
    <time_frame>Participants will be followed for the duration of hospital stay (expected: 10 days)</time_frame>
    <description>Postoperative use of antibiotics for postoperative infection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gastrointestinal complications</measure>
    <time_frame>Participants will be followed for the duration of hospital stay (expected: 10 days)</time_frame>
    <description>Any gastrointestinal complication requiring medical or surgical treatment after surgery</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">4000</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Myocardial Infarction</condition>
  <condition>Angina Pectoris</condition>
  <arm_group>
    <arm_group_label>Coronary artery bypass surgery</arm_group_label>
    <description>Patients undergoing coronary artery bypass surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Coronary artery bypass surgery</intervention_name>
    <description>Patients will undergo coronary artery bypass grafting</description>
    <arm_group_label>Coronary artery bypass surgery</arm_group_label>
    <other_name>Coronary artery bypass grafting</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population includes any patient undergoing isolated coronary artery bypass
        surgery.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients of aged &gt; 18 years undergoing isolated CABG for stable coronary artery
             disease or acute coronary syndrome. Patients undergoing Maze procedure will be
             included in this registry.

        Exclusion Criteria:

          -  Patients undergoing any other major cardiac surgery procedure will be excluded from
             this registry.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fausto Biancari, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>University of Oulu, Oulu, Finland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fausto Biancari, Professor</last_name>
    <phone>+358407333973</phone>
    <email>faustobiancari@yahoo.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Oulu University Hospital</name>
      <address>
        <city>Oulu</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fausto Biancari, Professor</last_name>
      <phone>+358407333973</phone>
      <email>faustobiancari@yahoo.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 23, 2014</study_first_submitted>
  <study_first_submitted_qc>December 17, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 18, 2014</study_first_posted>
  <last_update_submitted>July 3, 2015</last_update_submitted>
  <last_update_submitted_qc>July 3, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Oulu</investigator_affiliation>
    <investigator_full_name>Fausto Biancari</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>CABG</keyword>
  <keyword>Coronary artery bypass surgery</keyword>
  <keyword>Coronary artery bypass grafting</keyword>
  <keyword>Coronary surgery</keyword>
  <keyword>Myocardial infarction</keyword>
  <keyword>Coronary artery disease</keyword>
  <keyword>Off-pump</keyword>
  <keyword>EuroSCORE</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Angina Pectoris</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

